Systemic treatment of a patient with relapsed and refractory extranodal NK/T-cell lymphoma (ENKL) and meningeosis leukemica with daratumumab
Author:
Affiliation:
1. Department of Oncology/Haematology; Cantonal Hospital St. Gallen; St. Gallen Switzerland
2. Center for Laboratory Medicine; Hemostasis and Hemophilia Center; St. Gallen Switzerland
Publisher
Wiley
Subject
Cancer Research,Oncology,Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/hon.2533/fullpdf
Reference9 articles.
1. Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian oncology summit 2009;Kwong;Lancet Oncol,2009
2. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-cell tumor study group study;Yamaguchi;J Clin Oncol,2011
3. SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia lymphoma study group;Kwong;Blood,2012
4. Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease;Lim;Ann Oncol,2017
5. PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase;Kwong;Blood,2017
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and safety of PD‐1 inhibitor alone or combined with chemotherapy in patients with relapsed or refractory extranodal natural Killer/T cell lymphoma: A retrospective study;Hematological Oncology;2022-12-30
2. Review of daratumumab efficacy in all monoclonal gammopathies and other diseases and our experience with daratumumab, lenalidomide and dexamethasone therapy in 74 patients;Onkologie;2022-10-14
3. The clinical characteristics and prognostic factors of 410 patients with natural killer/T-cell lymphoma;Journal of Cancer Research and Clinical Oncology;2022-07-20
4. Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders;Cancers;2022-05-18
5. Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future Directions;Journal of Clinical Medicine;2022-05-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3